Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04985500 · ClinicalTrials.gov registry record · Early Phase 1
ESP/PIF for Sternotomy
A Early Phase 1 study of Cardiac Surgery and Sternotomy, sponsored by Icahn School of Medicine at Mount Sinai.
- Active
- Registry status
- Early Phase 1
- Development phase
- 225
- Enrollment target
- 1
- Study location
NCT04985500 is a Early Phase 1 study of Cardiac Surgery and Sternotomy that is active but no longer recruiting, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 225 participants, below the 734-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04985500, a Early Phase 1 study of Cardiac Surgery and Sternotomy, is active but no longer recruiting, sponsored by Icahn School of Medicine at Mount Sinai.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 225 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized study. The purpose of this study is to evaluate the effect of post-surgical pain control of two types of peripheral nerve blocks, specifically erector spinal plane (ESP) block and pecto-intercostal fascial (PIF) plane block. 90 subjects, from 18-85 years of age, undergoing cardiac surgery with median sternal incision will be enrolled at Mount Sinai Morningside Hospital Center. Study participation will last from the time of pre-operative evaluation to 72 hours after surgery. Subjects will be randomly assigned to receive 1 of the 3 different regimens at the beginning of surgery. Opioid consumption and pain scores after surgery will be evaluated. Though unlikely, risks include systemic absorption of local anesthetic, which can result in both central nervous system and cardiac toxicity.
Conditions Studied
Interventions
- DRUG Bupivacain
- PROCEDURE Ultrasound
- PROCEDURE ESP block
- PROCEDURE PIF block
Study Locations (1)
New York
- Mount Sinai Morningside Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2021-07-09 |
| Est. Completion | 2025-12-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04985500
The ClinicalTrials.gov registry entry for NCT04985500 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 734-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (69% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cardiac Surgery appearing as the primary indexed condition, and to 4 interventions - of which Bupivacain is the first listed.
NCT04985500 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04985500 about?
NCT04985500 is a clinical study titled "ESP/PIF for Sternotomy". This is a randomized study. The purpose of this study is to evaluate the effect of post-surgical pain control of two types of peripheral nerve blocks, specifically erector spinal plane (ESP) block and pecto-intercostal fascial (PIF) plane block. 90 subjects, from 18-85 years of age, undergoing card...
What is the current status of trial NCT04985500?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 225 participants. The study started on 2021-07-09. Estimated completion is 2025-12-31.
What conditions does trial NCT04985500 study?
This clinical trial studies the following conditions: Cardiac Surgery, Sternotomy.
What interventions are being tested in trial NCT04985500?
The interventions under investigation include: Bupivacain (DRUG), Ultrasound (PROCEDURE), ESP block (PROCEDURE), PIF block (PROCEDURE).
Who is sponsoring clinical trial NCT04985500?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04985500 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Study Evaluating the Advantages of Sucrosomial® Iron Post-operative Supplementation vs Standard of Care After Cardiac Surgery
RECRUITING · Early Phase 1
-
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
RECRUITING · NA
-
Oral Methadone in Cardiac Surgery
RECRUITING · Phase 4
-
Cardiopulmonary Bypass Induced Red Blood Cell Lysis
RECRUITING
-
Assessing the Burden of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
RECRUITING
-
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.